PhRMA 301 cases against India and Pakistan

[James Love <love@cptech.org>]

Scripts has a story about PhRMA's 301 filings against
India and Pakistan in the March 24 issue on page 14.

Much of the India filing focuses on compulsory licensing.
I would be interesting in getting an copy of the proposed
India legislation as it relates to this issue, since
the PhRMA summaries are notoriously biased. 

The Pakistan filings focus on price control issues, which
is odd, because price control issues are nor considered
IPR issues usually, and they are specifically excluded 
from the TRIPS.  

PhRMA India filing
http://www.phrma.org/issues/nte/india.html


PhRMA Pakistan filing
http://www.phrma.org/issues/nte/pakistan.html

-- 
James Love, Director, Consumer Project on Technology
I can be reached at love@cptech.org, by telephone 202.387.8030,
by fax at 202.234.5176. CPT web page is http://www.cptech.org